|
UBQLN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.278500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.303250E-03 |
| Normal-vs-Stage2 |
3.927600E-01 |
| Normal-vs-Stage3 |
3.803800E-02 |
| Normal-vs-Stage4 |
9.092300E-02 |
| Stage1-vs-Stage2 |
2.327200E-01 |
| Stage1-vs-Stage3 |
5.158600E-01 |
| Stage1-vs-Stage4 |
4.580000E-01 |
| Stage2-vs-Stage3 |
5.021200E-01 |
| Stage2-vs-Stage4 |
6.138400E-01 |
| Stage3-vs-Stage4 |
8.914600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.156000E-03 |
| Normal-vs-AfricanAmerican |
9.215200E-03 |
| Normal-vs-Asian |
1.386440E-02 |
| Caucasian-vs-AfricanAmerican |
2.945200E-01 |
| Caucasian-vs-Asian |
4.780800E-01 |
| AfricanAmerican-vs-Asian |
6.499400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.841700E-02 |
| Normal-vs-Female |
1.564860E-03 |
| Male-vs-Female |
4.353400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.169300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.998040E-02 |
| Normal-vs-Age(61-80Yrs) |
1.999430E-01 |
| Normal-vs-Age(81-100Yrs) |
8.841200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.706170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.176400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.010800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.234400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.920200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.816400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.456600E-01 |
| Classical-VS-Follicular |
3.07980000002761E-06 |
| Classical-VS-Other |
6.339700E-02 |
| Classical-VS-Normal |
2.29019999999913E-05 |
| Tall-VS-Follicular |
2.126400E-02 |
| Tall-VS-Other |
1.240420E-01 |
| Tall-VS-Normal |
4.598200E-02 |
| Follicular-VS-Other |
7.526000E-01 |
| Follicular-VS-Normal |
5.712200E-01 |
| Other-VS-Normal |
4.466800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.087800E-02 |
| Normal-vs-N1 |
4.306600E-01 |
| N0-vs-N1 |
4.897600E-01 |
|
|
